BeStock  
Markets › Compare › ZBH vs DXCM

ZBH vs DXCM

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ZBH · Zimmer Biomet Holdings$101.10 ▼ 0.36%
DXCM · DexCom$79.32 ▼ 1.08%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

8299117135152Nov 24, '25May 26, '26Nov 20, '26
  • ZBH +9.3%
  • DXCM +27.5%

Head to head

MetricZBHDXCM
Price$101.10$79.32
Change today▼ 0.36%▼ 1.08%
Market cap$19.13B$29.58B
Return, 3 months+0.4%-12.9%
Return, year to date+13.3%+19.5%
Return, 1 year+10.8%+31.7%
P/E (TTM)25.531.2
P/B1.511.7
P/E percentile vs own 5y46th6th
Dividend yield0.95%–
Revenue growth (YoY, latest qtr)+3.1%+11.2%
Net profit growth (YoY)-16.6%-3.1%
Gross margin69.7%63.4%
Operating margin16.3%24.0%
Net margin9.0%19.4%
Return on equity6.0%37.7%
Analyst target vs. price+17.2%+25.1%
Analyst buy share31%93%
RSI (14)5143
30-day volatility46.8%45.7%
Max drawdown, 1 year-21.0%-22.6%
Trend readLeaning bullishLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • DXCM is the largest of the group by market value.
  • DXCM has returned the most over the past year.
  • ZBH carries the lowest trailing P/E.
  • DXCM is growing revenue fastest.
  • DXCM keeps the most profit per dollar of sales.
  • DXCM has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top